← Back to Patent Explorer
US3936464A Expired / Lapsed US ⏱️ 0.0 years remaining

1-Acyl-3-[2-(4-phenyl-1-piperidinyl)ethyl]indolines

Assignee: Wyeth Holdings LLC
•
Filing: 1974-10-25
•
Granted: 1976-02-03
•
Expires: 1994-10-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract This disclosure describes new substituted 1-acyl-3-[2-(4-phenyl-1-piperidinyl)ethyl]indolines which possess hypotensive activity.

Inventors

  • 👤 George Rodger Allen, Jr.
  • 👤 Francis Joseph McEvoy

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 04:08
CPC Classifications
C; C07; C07D; C07D211/00; C07D211/04; C07D211/68; C07D211/70; C07D211/06; C07D211/36; C07D211/40; C07D211/44; C07D211/52

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 68 words
A compound selected from the group consisting of those of the formulae: ##SPC3## wherein R 1 is hydrogen or a lower alkoxy group, R 2 is hydrogen and R 1 and R 2 taken together is methylenedioxy, R 3 is a lower alkyl group, R 4 is hydrogen or a lower alkyl group, and R 5 is hydrogen, chloro or trifluoromethyl; and the pharmacologically acceptable acid-addition salts thereof.
Claim 2
Dependent Claim 68 words
A compound selected from the group consisting of those of the formulae: ##SPC3## wherein R 1 is hydrogen or a lower alkoxy group, R 2 is hydrogen and R 1 and R 2 taken together is methylenedioxy, R 3 is a lower alkyl group, R 4 is hydrogen or a lower alkyl group, and R 5 is hydrogen, chloro or trifluoromethyl; and the pharmacologically acceptable acid-addition salts thereof.
Claim 3
Dependent Claim 32 words
The compound according to claim 1, formula (II) thereof, wherein R 1 is hydrogen, R 2 is hydrogen, R 3 is methyl, R 4 is hydrogen, and R 5 is hydrogen; 1-acetyl-3-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridyl)ethyl]indoline.
Claim 4
Dependent Claim 32 words
The compound according to claim 1, formula (I) thereof, wherein R 1 is hydrogen, R 2 is hydrogen, R 3 is methyl, R 4 is hydrogen, and R 5 is hydrogen; 1-acetyl-3-[2-(4-phenylpiperidino)ethyl]indoline.
Claim 5
Dependent Claim 32 words
The compound according to claim 1, formula (II) thereof, wherein R 1 is hydrogen, R 2 is hydrogen, R 3 is methyl, R 4 is hydrogen, and R 5 is para-chloro; 1-acetyl-3-{2-[4-(p-chlorophenyl)-3,6-dihydro-1(2H)-pyridyl]ethyl}indoline.
Claim 6
Dependent Claim 33 words
The compound according to claim 1, formula (II) thereof, wherein R 1 and R 2 taken together is methylenedioxy, R 3 is methyl, R 4 is hydrogen, and R 5 is hydrogen; 5-acetyl-7-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridyl)ethyl]-6,7-dihydro-5H-1,3-dioxolo[4,5-f]indole.
Claim 7
Dependent Claim 32 words
The compound according to claim 1, formula (II) thereof, wherein R 1 is methoxy, R 2 is hydrogen, R 3 is methyl, R 4 is methyl, and R 5 is hydrogen; 1-acetyl-3-[2-(3,6-dihydro-4-phenyl-1(2H)-pyridyl)ethyl]-5-methoxy-2-methylindoline.
Claim 8
Dependent Claim 33 words
The compound according to claim 1, formula (I) thereof, wherein R 1 and R 2 taken together is methylenedioxy, R 3 is methyl, R 4 is hydrogen, and R 5 is hydrogen; 5-acetyl-6,7-dihydro-7-[2-(4-phenylpiperidino)ethyl]-5H-1,3-dioxolo-[4,5-f]indole.
Claim 9
Dependent Claim 32 words
The compound according to claim 1, formula (I) thereof, wherein R 1 is methoxy, R 2 is hydrogen, R 3 is methyl, R 4 is methyl, and R 5 is hydrogen; 1-acetyl-5-methoxy-2-methyl-3-[2-(4-phenyl-1-piperidno)ethyl]indoline.
Claim 10
Dependent Claim 32 words
The compound according to claim 1, formula (II) thereof, wherein R 1 is hydrogen, R 2 is hydrogen, R 3 is methyl, R 4 is hydrogen, and R 5 is para-trifluoromethyl; 1-acetyl-3-{2-[3,6-dihydro-(α,α,α-trifluoro-p-tolyl)-1(2H)-pyridyl]-ethyl}indoline.
Claim 11
Dependent Claim 32 words
The compound according to claim 1, formula (I) thereof, wherein R 1 is hydrogen, R 2 is hydrogen, R 3 is methyl, R 4 is hydrogen, and R 5 is para-trifluoromethyl; 1-acetyl-3{2-[4-(α,α,α-trifluoro-p-tolyl)piperidino]ethyl}indoline.

References Cited (Backward Citations)

US3527761A Cited
US3564009A Cited
US3639414A Cited
US3655674A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-02-02 1979-08-04 1980-02-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-02-02 1983-08-04 1984-02-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-02-02 1987-08-04 1988-02-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag